Advances in Immunotherapy Clinical Trials: Putting Patients First

In this latest CRI cancer immunotherapy webinar for patients and caregivers, Dr. Joshua Brody -- a CRI-funded scientist at The Icahn School of Medicine at Mt. Sinai in New York City -- and a breast cancer patient, Stephanie Gangi, will discuss the value clinical trials can offer patients and how the patient voice has become increasingly important when planning clinical studies. Stephanie has been navigating breast cancer for more than twenty years, and it is a new vaccine approach based on Dr. Brody's CRI-funded work that is keeping her healthy and hopeful for herself and other cancer patients now benefiting from advances in cancer immunotherapy.

Funding for our webinar series has been generously provided by Bristol Myers Squibb, with additional funding provided by Alkermes, BioCanRx, and Lilly Oncology.

Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.

[Alpha_]

What a great explanation. You made it so easy to understand to a layman like myself who is receiving Nivolumab to ensure I don't get oesophageal cancer once more or to ensure it doesn't metastisise. Cheers.

[usaintltrade]

HEALTH CARE SYSTEM THAT HEALS WITHOUT PREJUDICE WITHOUT DELAY 🇺🇲🗽⚖️🧬🛡️📜🥇

[luciususiholo]

Xcures could help with getting people immunotherapy trials